Chemcrux Enterprises Limited engages in the manufacture and sale of intermediates and chemicals in India. Its chemicals and intermediates products are used in the manufacture of bulk drugs active pharmaceutical ingredients, electro-plating, pharmaceuticals, dyes, and pigments. The company offers chloro benzoic acid, nitro benzoic acid, nitro salicylic, dichloro benzoic acid, chloro nitro benzoic acid, lasamide, arabonic acid sodium salt, chloro benzoic acid sulfonamide, BPEA sulfonamide, para and ortho chloro benzoyl chloride, and chloro benzoyl chloride. It serves multinationals and pharmaceutical organizations. The company also exports its products. Chemcrux Enterprises Limited was founded in 1983 and is based in Vadodara, India.
| Current Price | ₹90.66 |
|---|---|
| Market Cap | ₹134 Cr |
| Sector | Materials > Materials > Chemicals |
| Sub-Industry | Commodity Chemicals > Industrial Inorganic Chemicals |
| P/E Ratio | 36 |
| Return on Equity | 4.93% |
| 52-Week Range | ₹64.00 – ₹158.60 |
| Beta (1Y) | 0.95 |
| Dividend Yield | 1.10% |
1. Bulk Drug Intermediates and Its Related Products-100%
Chemcrux Enterprises Ltd is trading at ₹90.66, with a market capitalisation of ₹134 Cr.
Chemcrux Enterprises Ltd operates in the Materials > Materials > Chemicals space (Commodity Chemicals > Industrial Inorganic Chemicals).
Chemcrux Enterprises Ltd has a P/E of 36 and a return on equity of 4.93%.